Abstract
AbstractAnti-n-methyl-d-aspartate receptor (NMDAR) encephalitis is a form of autoimmune encephalitis that remains under-recognized due to the variability of the initial symptoms and can be misdiagnosed as viral encephalitis or other pathogens. This syndrome has been predominantly described in young females including personality changes, autonomic dysfunctions, and neurologic decompensation.About half of the cases have tumors, most commonly teratomas of the ovaries; another established trigger is herpes viral encephalitis, while the cause in other cases is unclear. In case of clinical suspicion, electroencephalogram and brain magnetic resonance imaging are useful, but lumbar puncture for cerebrospinal fluid analysis is used to confirm the diagnosis. Treatment for this disease includes immunosuppression, plasmapheresis, and tumor resection when indicated. In this case report, we present a case that presented with hyperreligiosity and proved to have autoimmune encephalitis.The main purpose of our case is to increase awareness regarding immune-mediated encephalitis, especially the anti-NMDAR encephalitis.
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science,Cell Biology,Developmental Biology,Embryology,Anatomy
Reference13 articles.
1. Kayser MS, Dalmau J (2011) ant-NMDA receptor encephalitis in psychiatry. Current psychiatry Rev 7(3):189–183
2. Wang D, Fries B (2014) Anti-NMDAR encephalitis, a mimicker of acute infectious encephalitis and a review of the literature. ID cases 1(4):66–67
3. Barry H, Byrne S, Barret E et al (2015) anti-N-methyl-D-aspartate –receptor encephalitis: a review of clinical presentation, diagnosis, and treatment. BJ Psych Bull 39(1):19–23
4. Kayser MS, Dalmau J (2016) Anti-NMDA receptor encephalitis , autoimmunity and psychosis https://www.ncbi.nlm.nih.gov/PMC4409922. Schizophr Res 176(1):3640. https://doi.org/10.1016/j.schres.2014.10.007(10.1016%2Fj.schres.2014.10,00
5. Venkatesan A, Adatia K (2017) Anti-NMDA-receptor encephalitis from bench to clinic. ACS Chem Neurosci 8(12):2586–2595